div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=document37-22-e-577-l-eusafna-neuroendocrine-carcinoma-daffij-ct-ct-1-l-cthtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: 37 22 E 577 · l EUS—FNA neuroendocrine carcinoma D—ffiJ CT CT 1 l CT l CT l MD MD 2 2 MTX 2 CT CT MT CT CT 0 CT CT % CT N MD N MD MD loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumenticomreader033viewer202206100260b0b24681eb12204d77e1e2html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=document37-22-e-577-l-eusafna-neuroendocrine-carcinoma-daffij-ct-ct-1-l-cthtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: 37 22 E 577 · l EUS—FNA neuroendocrine carcinoma D—ffiJ CT CT 1 l CT l CT l MD MD 2 2 MTX 2 CT CT MT CT CT 0 CT CT % CT N MD N MD MD loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumenticomreader033viewer202206100260b0b24681eb12204d77e1e2html5thumbnails2jpg width=140 height=200 divdiv